Please Note:
This module was delivered in Spanish. English captions can be enabled when viewing the lesson by hovering over the video and toggling the closed captions button.
La tetralogía de Fallot es un defecto de nacimiento que afecta el flujo normal de sangre por el corazón. Se produce cuando el corazón del bebé no se forma correctamente mientras crece y se desarrolla en el vientre materno durante el embarazo. En esta conversación colaborativa, presentamos las opiniones de 5 especialistas: CHOP, República Dominicana, Colombia y Panamá, intercambiando sus conocimientos, opiniones y situaciones en cada país de origen.
El Centro de Cardiología de Children’s Hospital of Philadelphia (CHOP) atiende a niños desde antes de su nacimiento hasta la edad adulta. Es uno de los centros más grandes del mundo de atención de niños y jóvenes adultos con afecciones cardiacas congénitas y adquiridas.
El Programa de Cardiología Fetal es líder nacional en evaluación, diagnóstico y tratamiento de enfermedades cardíacas fetales.
Cada año, el centro atiende más de 32,000 visitas de pacientes ambulatorios, y la División de Cirugía Cardiotorácica realiza más de 1,000 procedimientos, incluidas más de 600 cirugías a corazón abierto. En el Laboratorio de Cateterismo Cardíaco de CHOP, nuestro equipo de expertos realiza más de 1,300 procedimientos de cateterismo cardíaco cada año a recién nacidos, lactantes, niños y jóvenes adultos.
Objetivos de aprendizaje :
- Definir la tetralogía de Fallot junto con su presentación, síntomas y opciones de tratamiento
- Comprender cómo el diagnóstico y el tratamiento de la tetralogía de Fallot difieren en diferentes áreas del mundo
Oradores :
- Laura M. Mercer-Rosa, MD, MSCE
- Ramiro Lizano Santamaria, MD
- Miguel De la Rosa, MD
- Heidy Barrios-Taibel, MD
- Yanet Toribio, MD, FACC
Este seminario se centra en cardiología y se impartió virtualmente para el Children’s Hospital of Philadelphia el 30 de mayo de 2024.
Palabras clave del curso: Cardiología, Fallot, Salud Global, Spanish
English Translation:
Tetralogy of Fallot is a birth defect that affects the normal flow of blood through the heart. It occurs when the baby’s heart does not form correctly as it grows and develops in the womb during pregnancy. In this collaborative conversation, we present the opinions of 5 specialists: CHOP, Dominican Republic, Colombia and Panama, exchanging their knowledge, opinions, and situations in each country of origin.
The Cardiology Center at Children’s Hospital of Philadelphia (CHOP) cares for children from before birth to adulthood. It is one of the largest centers in the world for the care of children and young adults with congenital and acquired heart conditions.
The Fetal Cardiology Program is a national leader in the evaluation, diagnosis and treatment of fetal heart disease.
Each year, the center sees more than 32,000 outpatient visits, and the Division of Cardiothoracic Surgery performs more than 1,000 procedures, including more than 600 open heart surgeries. At CHOP’s Cardiac Catheterization Laboratory, our team of experts performs more than 1,300 cardiac catheterization procedures each year on newborns, infants, children, and young adults.
Learning Objectives:
- Define tetralogy of Fallot along with its presentation, symptoms, and treatment options
- Understand how the diagnosis and treatment of Tetralogy of Fallot differs in different areas of the world
Speakers:
- Laura M. Mercer-Rosa, MD, MSCE
- Ramiro Lizano Santamaria, MD
- Miguel De la Rosa, MD
- Heidy Barrios-Taibel, MD
- Yanet Toribio, MD, FACC
This seminar focuses on cardiology and was delivered virtually for Children’s Hospital of Philadelphia on May 30, 2024.
Course Keywords: Cardiology, Fallot, Global Health, Spanish
Content Disclaimer
The Terms of Use and Privacy Policy set forth on the website of The Children’s Hospital of Philadelphia apply to any and all uses of and access to this site and the content found here.
The work presented in the presentations, videos, and other content on this site (“Presentations”) includes publicly available medical evidence, a consensus of medical practitioners, and/or opinions of individual practitioners that may differ from consensus opinions. These Presentations are intended only to provide general information and need to be adapted for each specific patient based on the practitioner’s professional judgment, consideration of any unique circumstances, the needs of each patient and their family, the availability of various resources at the health care institution where the patient is located, and other factors. The Presentations are not intended to constitute medical advice or treatment, nor should they be relied upon as such. The Presentations are not intended to create a doctor-patient relationship between/among The Children’s Hospital of Philadelphia, its physicians and the individual patients in question. The information contained in these Presentations are general in nature, and do not and are not intended to refer to specific patients.
CHOP, The Children’s Hospital of Philadelphia Foundation and its or their affiliates, the authors, presenters, practitioners, editors, and others associated with the creation of the Presentations (“CHOP”) are not responsible for errors or omissions in the Presentations; for any outcomes a patient might experience where a clinician reviewed one or more such Presentations in connection with providing care for that patient; and/or for any and all third party content on the site or in the Presentations. CHOP makes no warranty, expressed or implied, with respect to the currency, completeness, applicability or accuracy of the Presentations. Application of the information in or to a particular situation remains the professional responsibility of the practitioner who is directly treating the patient.
To the extent that the Presentations include information regarding drug dosing, in view of ongoing research, changes in government regulations and the constant flow of information relating to drug therapy and drug reactions, the viewer should not rely on the Presentation content, but rather is urged to check the package insert for each drug for indications, dosage, warnings and precautions.
Some drugs and medical devices presented in the Presentations have United States Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the practitioner to ascertain the FDA status of each drug or device planned for use in their clinical practice.
You shall indemnify, defend and hold harmless CHOP, The Children’s Hospital of Philadelphia Foundation, and its/their current and former employees, officers, and agents, trustees, and their respective successors, heirs and assigns (“Indemnitees”) against any claims, liability, damage, loss or expenses (including attorneys’ fees and expenses of litigation) in connection with any claims, suits, actions, demands or judgments arising directly or indirectly out of your reference to or use of the Presentations.
The Presentations are protected by copyright laws and in some cases patent laws, and all rights are reserved under such laws. No part of the Presentations may be reproduced in any form by any means, or utilized in any other way, absent prior written permission from the copyright owner.
By starting this module, you agree to our Content Disclaimer and Terms of Service.